Drug Trial Radar · NCT06744686
Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients With Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
56
Actual
Start
Jun 12, 2023
Primary completion
Mar 12, 2024
Study completion Jun 18, 2024
Sponsor
- Lead sponsor
- Suzhou HepaThera Biotech Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of HT-102 (BM012) Injection in Healthy Subjects and Hepatitis B e Antigen-Negative Patients with Chronic Hepatitis B Virus Infection: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Subcutaneous Injections, and Dose Escalation Phase 1 Clinical Study
Conditions
- Chronic Hepatitis B
Interventions
HT-102Drug
50mg, 150mg, 300mg, 600mg
HT-102Drug
50mg, 150mg, 300mg
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: From administration to the end of treatment at 8 weeks
- Time to Reach Maximum Plasma Concentration (Tmax)Time frame: From administration to the end of treatment at 8 weeks
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Mengchao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, China
People's Hospital of Qingyuan
Qingyuan, Guangdong, China
Luoyang Central Hospital
Luoyang, Henan, China
The Sixth People's Hospital of Zhengzhou
Zhengzhou, Henan, China
Shandong Public Health Clinical Center
Jinan, Shandong, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.